+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Amiodarone"

Critical Care Antiarrhythmic Drugs Market Report 2025 - Product Thumbnail Image

Critical Care Antiarrhythmic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Amiodarone is a medication used to treat irregular heartbeats and other cardiac arrhythmias. It is a class III antiarrhythmic drug, and is one of the most commonly prescribed drugs in the cardiovascular drug market. It works by blocking certain electrical signals in the heart, which helps to regulate the heart rate. Amiodarone is used to treat a variety of conditions, including atrial fibrillation, ventricular tachycardia, and ventricular fibrillation. It is also used to prevent recurrent episodes of atrial fibrillation and ventricular tachycardia. Amiodarone is available in both oral and intravenous forms, and is generally well tolerated. Common side effects include nausea, vomiting, and dizziness. More serious side effects can include liver damage, thyroid problems, and pulmonary toxicity. The amiodarone market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Sanofi, GlaxoSmithKline, and Merck. Show Less Read more